HURA · TuHURA Biosciences, Inc. · Documents
Market Cap
$128.09M
Shares
63.73M
Volume · Oct 22
609.26K
Avg daily vol (3M)
240.34K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | On October 9, 2026, TuHURA Biosciences, Inc. borrowed an additional $650,000 under its $50 million revolving credit facility with Parkview Holdings One LLC, which matures April 21, 2031; funds will support general corporate purposes. | 2026-10-16 | 2026-10-09 | |
| 8-K | — | 2026-09-24 | 2026-09-21 | |
| 8-K | — | 2026-09-17 | 2026-09-14 | |
| 8-K/A | — | 2026-09-17 | 2026-09-10 | |
| 8-K | — | 2026-09-16 | 2026-09-10 | |
| 8-K | — | 2026-09-04 | 2026-09-02 | |
| 8-K | — | 2026-08-21 | 2026-08-20 | |
| 8-K | — | 2026-08-19 | 2026-08-18 | |
| 10-Q | — | 2026-08-14 | 2026-06-30 | |
| 8-K | — | 2026-08-14 | — | |
| 8-K | — | 2026-08-13 | 2026-08-07 | |
| Investor Event Transcript | — | 2026-08-12 | 2026-09-30 | |
| 8-K | — | 2026-07-29 | 2026-07-28 | |
| DEFA14A | — | 2026-07-09 | — | |
| DEF 14A | — | 2026-07-09 | 2026-08-18 | |
| ARS | — | 2026-07-09 | 2025-12-31 | |
| 8-K | — | 2026-07-07 | 2026-06-30 | |
| PRE 14A | — | 2026-06-26 | 2026-08-18 | |
| 8-K | — | 2026-06-17 | — | |
| 8-K | — | 2026-05-29 | 2026-05-26 | |
| 10-Q | — | 2026-05-15 | 2026-03-31 | |
| 8-K | — | 2026-05-15 | — | |
| 10-K/A | — | 2026-04-30 | 2025-12-31 | |
| 8-K/A | — | 2026-04-30 | 2026-04-02 | |
| 8-K | — | 2026-04-22 | 2026-04-21 | |
| 8-K | — | 2026-04-08 | 2026-04-02 | |
| 8-K | — | 2026-04-01 | — | |
| 10-K | — | 2026-03-31 | 2025-12-31 | |
| 8-K | — | 2026-01-30 | 2026-01-29 | |
| 8-K | — | 2025-12-10 | 2025-12-09 | |
| 8-K | — | 2025-12-05 | 2025-12-02 | |
| 8-K | — | 2025-11-25 | — | |
| 8-K | — | 2025-11-18 | — | |
| 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-11-14 | — | |
| 8-K | — | 2025-11-04 | 2025-11-03 | |
| 8-K | — | 2025-11-03 | — | |
| S-3 | — | 2025-11-03 | — | |
| 8-K | — | 2025-10-31 | 2025-10-27 | |
| S-1/A | — | 2025-09-18 | — | |
| 8-K | — | 2025-09-11 | 2025-09-05 | |
| 10-Q | — | 2025-08-14 | 2025-06-30 | |
| 8-K | — | 2025-08-14 | — | |
| 8-K/A | — | 2025-08-12 | 2025-06-30 | |
| S-1 | — | 2025-08-12 | — | |
| 8-K | — | 2025-06-30 | — | |
| 8-K | — | 2025-06-27 | 2025-06-23 | |
| 8-K | — | 2025-06-24 | 2025-06-23 | |
| 8-K | — | 2025-06-12 | 2025-06-06 | |
| 8-K | — | 2025-06-06 | 2025-06-02 |
Showing 1–50 of 210 filings
Key facts
CIK
1498382
CUSIP
898920103
13F (30d)
12 filings
12 filers
Visit website
Investor relations